This cohort includes 5 distinct small variants, all successfully annotated. The headline finding is a single high-confidence Pathogenic frameshift variant in BRCA2 in a background otherwise dominated by missense variants of uncertain or reduced clinical significance and one common benign variant.

## Cohort statistics

**Overall classification (simplified ACMG/AMP engine)**  
- Pathogenic: 1 / 5  
- Uncertain significance (VUS): 2 / 5  
- Likely benign: 1 / 5  
- Benign: 1 / 5  

**ClinVar clinical significance (MyVariant.info)**  
- Pathogenic: 3  
- Conflicting interpretations of pathogenicity: 1  
- Not provided: 1  

This shows that while ClinVar lists 3 variants as Pathogenic, the internal simplified ACMG/AMP engine ultimately classified only 1 as Pathogenic for this exercise, tempering the others based on allele frequency and other criteria.

**Variant type / predicted consequence (Ensembl VEP)**  
- Missense variants: 4  
- Frameshift variants: 1  

Missense changes constitute the majority of the cohort, with a single truncating (frameshift) variant that drives the main Pathogenic hit.

**Allele-frequency profile (gnomAD via MyVariant.info)**  
- Variants with gnomAD AF available: 5 / 5  
- Rare (AF < 1×10⁻⁴): 0  
- Common (AF > 5%): 1  
- Minimum AF: 0.000291185  
- Median AF: 0.00347958  
- Maximum AF: 0.314859  

Thus, there are no ultra-rare variants in this small cohort; most are at low-to-moderate frequencies, with one very common variant (>30% in gnomAD) that informed a Benign classification.

## Notable variants

### Pathogenic BRCA2 frameshift (chr13:g.32340300GT>G, rs80359550)

- Gene: BRCA2  
- Variant: chr13:g.32340300GT>G  
- dbSNP: rs80359550  
- Most severe consequence: frameshift_variant  
- gnomAD AF: 0.000291185 (rare but clearly observed)  
- ClinVar significance: Pathogenic  
- ClinVar review status: criteria provided, multiple submitters, no conflicts  
- Simplified ACMG/AMP classification: Pathogenic  
- Applied criteria: PVS1 (predicted null/LOF in a gene where LOF is known disease mechanism), PP5 (reputable source/ClinVar pathogenic annotation)

This is the key disease-associated finding in the cohort: a rare, loss-of-function BRCA2 frameshift variant aligning with strong ClinVar evidence and the internal classifier’s Pathogenic call. The low but nonzero allele frequency is consistent with a high-penetrance cancer susceptibility variant in population datasets.

### ClinVar Pathogenic but internal VUS / Likely benign calls

These illustrate tensions between database labels and allele-frequency–informed interpretation:

1. **GBA missense (chr1:g.155235252A>G, rs421016)**  
   - Gene: GBA  
   - Variant: chr1:g.155235252A>G (missense_variant)  
   - dbSNP: rs421016  
   - gnomAD AF: 0.0012957  
   - ClinVar significance: Pathogenic (criteria provided, multiple submitters, no conflicts)  
   - In silico: SIFT D (deleterious), PolyPhen P (possibly damaging)  
   - Simplified ACMG/AMP classification: Uncertain significance (VUS)  
   - Applied criteria: PP3 (supporting pathogenic, computational), PP5 (supportive ClinVar/other)  

   Despite a strong ClinVar Pathogenic label and deleterious in silico scores, the simplified classifier did not elevate this to Pathogenic. The likely reasons include modest but non-ultrarare population frequency and a conservative rule set that reserves strong classifications for variants with high-impact consequences (e.g., truncating) or additional segregation/functional evidence (not modeled here). This is a prime example of a database-pathogenic variant being treated more cautiously in an educational framework.

2. **HFE missense (chr6:g.26092913G>A, rs1800562)**  
   - Gene: HFE  
   - Variant: chr6:g.26092913G>A (missense_variant; commonly known C282Y)  
   - dbSNP: rs1800562  
   - gnomAD AF: 0.0332118 (~3.3%)  
   - ClinVar significance: Pathogenic (criteria provided, multiple submitters, no conflicts)  
   - In silico: SIFT D; PolyPhen D/P (damaging)  
   - Simplified ACMG/AMP classification: Likely benign  
   - Applied criteria: PP3 (supporting pathogenic, in silico), PP5 (supportive ClinVar), BS1 (allele frequency too high for a fully penetrant severe disorder)

   The high allele frequency prompted the BS1 benign-supporting criterion, which, in this simplified framework, outweighs the ClinVar Pathogenic label. This reflects an educational emphasis that a variant common in the general population is unlikely to cause a rare, fully penetrant Mendelian disease, even if ClinVar lists it as Pathogenic (the real-world nuance is that this variant is associated with a relatively common, often low-penetrance condition, not modeled here).

### Common MTHFR variant with conflicting ClinVar assertions (chr1:g.11796321G>A, rs1801133)

- Gene: MTHFR  
- Variant: chr1:g.11796321G>A (missense_variant)  
- dbSNP: rs1801133 (C677T)  
- gnomAD AF: 0.314859 (~31%)  
- ClinVar significance: Conflicting interpretations of pathogenicity  
- ClinVar review status: no assertion criteria provided  
- In silico: SIFT D; PolyPhen D (both suggest damaging)  
- Simplified ACMG/AMP classification: Benign  
- Applied criteria: PP3 (computational support), BA1 (standalone benign: extremely common in population)

Despite in silico predictions and mixed ClinVar assertions, the very high allele frequency triggers BA1, leading to a Benign classification in this simplified system. This highlights how population frequency can override computational and low-confidence clinical assertions.

### HBB missense VUS (chr11:g.5227002T>A, rs334)

- Gene: HBB  
- Variant: chr11:g.5227002T>A (missense_variant; HbS / sickle variant)  
- dbSNP: rs334  
- gnomAD AF: 0.00347958  
- ClinVar significance: not provided  
- ClinVar review status: no assertion provided  
- In silico: SIFT D, PolyPhen B (mixed predictions)  
- Simplified ACMG/AMP classification: Uncertain significance (VUS)  
- Applied criteria: PP3 (supportive computational)

Because ClinVar does not provide a formal assertion and evidence is modeled only through limited computational data and frequency, the classifier remains conservative and labels this as VUS, not attempting to encode the well-established clinical context of sickle hemoglobin.

## Patterns & caveats

1. **VUS burden and discordance with ClinVar**  
   - 2 of 5 variants are VUS in this framework, including at least one with strong ClinVar Pathogenic assertions (GBA).  
   - This underscores that different rule sets, and especially different use of population data, can substantially alter final classifications.

2. **No ultra-rare variants**  
   - None of the variants have AF < 1×10⁻⁴; the rarest (BRCA2 frameshift) still appears in gnomAD at ~3×10⁻⁴.  
   - The absence of ultra-rare variants limits the ability of this toy cohort to illustrate classic “private variant” interpretations.

3. **High-frequency variants driving benign calls**  
   - The very common MTHFR variant (AF ~31%) and the relatively common HFE variant (AF ~3.3%) show how BA1/BS1 criteria can override other lines of evidence.  
   - This is particularly important in genes where certain “pathogenic” variants are associated with common, sometimes low-penetrance, or context-dependent phenotypes (not fully modeled here).

4. **Missense vs truncating effects**  
   - The only clear Pathogenic classification is for a truncating BRCA2 frameshift with strong external evidence.  
   - All missense variants fall into VUS, Likely benign, or Benign, despite several having ClinVar Pathogenic labels and damaging in silico predictions. This reflects the conservative nature of interpreting missense variants without rich functional or segregation data.

5. **In-silico prediction disagreements and limitations**  
   - There are notable disagreements between SIFT and PolyPhen (e.g., HBB: SIFT D vs PolyPhen B).  
   - In several cases, “damaging” computational predictions coexist with Benign or Likely benign classifications due to high allele frequency, illustrating that in silico tools provide at most supporting evidence and cannot by themselves establish pathogenicity.

6. **No unannotated variants**  
   - All 5 variants were successfully annotated (0 unannotated), which simplifies interpretation but does not reflect the more challenging real-world scenario where many variants lack any database support.

Overall, this small cohort is useful for demonstrating how allele frequency, variant consequence, and differences between database annotations and local rule implementations can lead to apparently conflicting classifications, and why classification must always be contextualized and conservative when evidence is incomplete.

## Data sources

- **MyVariant.info** for aggregation of:  
  - ClinVar clinical significance and review status  
  - gnomAD population allele frequencies  
  - dbNSFP-derived in silico predictions where available (SIFT, PolyPhen, etc.)  
- **Ensembl Variant Effect Predictor (VEP)** for determination of most severe consequence (e.g., missense_variant, frameshift_variant) on canonical transcripts.

> **DISCLAIMER -- RESEARCH / EDUCATION ONLY. NOT FOR CLINICAL USE.** This memo was generated by an automated teaching pipeline using a simplified ACMG/AMP heuristic subset and must not be used to diagnose, treat, or make any medical decision. Clinical interpretation requires a qualified molecular geneticist in an accredited (CAP/CLIA) laboratory.